Pharmaceutical giant Moderna and trading platform Robinhood have joined our growing list of +150 assets. Here’s what you need to know!
Two of the biggest stocks on the market, Moderna (MRNA) and Robinhood (HOOD), have joined our growing list of +150 assets.
In this article, we will highlight these two companies and share advice on how you can invest.
Moderna – vaccine specialist soars in value
The arrival of COVID-19 vaccines promises a return to normal(ish) life for billions around the world suffering from the ongoing pandemic. This has created a global market worth tens of billions of dollars in annual sales for pharmaceutical companies such as Moderna.
Moderna was founded 11 years ago and employed a mere 830 staff pre-pandemic. In 2021, it expects to make billions from its mRNA vaccine. Earlier in 2021, the UK ordered 17 million doses, the EU 310 million, and the US government ordered 300 million shots.
The vaccine has brought Moderna revenue of $1.73 billion in the first quarter of 2021 and $4.4 billion in Q2. Earnings per share totaled $6.46. Overall, its stock price has quadrupled since the end of 2020; 98.51% in the past six months and 217.19% YTD. Moderna raised its full-year forecast of COVID-19 vaccine sales to $19.2 billion, based on advance purchase agreements representing 50 countries.
What’s next for the company?
The company said it would explore a combination vaccine that aims to offer protection against the common flu and COVID-19.
Stéphane Bancel, Chief Executive Officer of Moderna: “We are pleased that our COVID-19 vaccine is showing durable efficacy of 93% through six months but recognize that the Delta variant is a significant new threat so we must remain vigilant.”
“We have begun preparing late-stage studies for our flu vaccine and RSV vaccine, which received fast track designation from the FDA a few days ago and are looking forward towards our vision of a single dose annual booster that protects against COVID-19, flu, and RSV for adults.”
Robinhood – US trading giant gets its IPO
US trading platform Robinhood has been drawing a lot of attention lately. The group launched its IPO earlier in July 2021 and its price movements have been a rollercoaster. At its initial offering, its stock closed up 50.4% at $70.39 per share even reaching $85 at one point. After running up 87% between Aug 2 and 4, HOOD stock then plunged 28% to $50.97 on Aug. 5 and continued to drop. Fortunately, it has stabilized and trading below $50 at the time of publishing (August 17). Overall, it is still a significant improvement from an initial $35 to its current price of $47.
Robinhood ended Q1 with 17.7 million monthly active users and is managing $80 billion in assets. Analysts are expecting Robinhood to report revenue of $521.8 million in Q2.
What’s next for the company?
Robinhood has announced in August that it will acquire tech start-up Say Technologies in a deal worth $140 million.
It is a significant deal as it’s Robinhood’s first major acquisition since going public. Analysts believe it shows where the trading platform may look to invest some of its newly acquired liquid equity from its IPO.
Want to Invest in these companies?
We’re giving all our clients an opportunity to get their share of these two companies as we add them to our growing list of +150 assets.
How it works
The new stocks are available for trading from August 16.
The contract size for both will be 100 shares for 1 lot and the leverage for both will be set to 1:2.
Clients will be able to trade as low as 0.01 of a lot.
Here’s how you can start trading today:
- Open a trading account
- Download the trading platform.
- Start trading!
If you have any questions, please do not hesitate to contact one of our customer support representatives or your trading specialist!